These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 35159097)

  • 1. Dissecting
    Lazarenkov A; Sardina JL
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function.
    Stoyanova E; Riad M; Rao A; Heintz N
    Elife; 2021 Dec; 10():. PubMed ID: 34919053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
    Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
    Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TET proteins and 5-methylcytosine oxidation in hematological cancers.
    Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
    Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated
    Xu B; Wang H; Tan L
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insight into substrate preference for TET-mediated oxidation.
    Hu L; Lu J; Cheng J; Rao Q; Li Z; Hou H; Lou Z; Zhang L; Li W; Gong W; Liu M; Sun C; Yin X; Li J; Tan X; Wang P; Wang Y; Fang D; Cui Q; Yang P; He C; Jiang H; Luo C; Xu Y
    Nature; 2015 Nov; 527(7576):118-22. PubMed ID: 26524525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Modification of Cytosines in Hematopoietic Differentiation and Malignant Transformation.
    An J; Ko M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in DNA methylation: 5-hydroxymethylcytosine revisited.
    Dahl C; Grønbæk K; Guldberg P
    Clin Chim Acta; 2011 May; 412(11-12):831-6. PubMed ID: 21324307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of TET-mediated DNA demethylation suppresses osteoblast differentiation.
    Dusadeemeelap C; Rojasawasthien T; Matsubara T; Kokabu S; Addison WN
    FASEB J; 2022 Feb; 36(2):e22153. PubMed ID: 34997955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct and stage-specific contributions of TET1 and TET2 to stepwise cytosine oxidation in the transition from naive to primed pluripotency.
    Mulholland CB; Traube FR; Ugur E; Parsa E; Eckl EM; Schönung M; Modic M; Bartoschek MD; Stolz P; Ryan J; Carell T; Leonhardt H; Bultmann S
    Sci Rep; 2020 Jul; 10(1):12066. PubMed ID: 32694513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
    Poole CJ; Lodh A; Choi JH; van Riggelen J
    Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma.
    Wang P; Yan Y; Yu W; Zhang H
    Cell Prolif; 2019 Jul; 52(4):e12626. PubMed ID: 31033072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tet Enzymes, Variants, and Differential Effects on Function.
    Melamed P; Yosefzon Y; David C; Tsukerman A; Pnueli L
    Front Cell Dev Biol; 2018; 6():22. PubMed ID: 29556496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies.
    Lio CJ; Yuita H; Rao A
    Blood; 2019 Oct; 134(18):1487-1497. PubMed ID: 31467060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive/negative ion-switching-based LC-MS/MS method for quantification of cytosine derivatives produced by the TET-family 5-methylcytosine dioxygenases.
    Dey AS; Ayon NJ; Bhattacharya C; Gutheil WG; Mukherji M
    Biol Methods Protoc; 2020; 5(1):bpaa019. PubMed ID: 33376805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation.
    Ficz G; Branco MR; Seisenberger S; Santos F; Krueger F; Hore TA; Marques CJ; Andrews S; Reik W
    Nature; 2011 May; 473(7347):398-402. PubMed ID: 21460836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.
    Nakajima H; Kunimoto H
    Cancer Sci; 2014 Sep; 105(9):1093-9. PubMed ID: 25040794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells.
    Xu Y; Wu F; Tan L; Kong L; Xiong L; Deng J; Barbera AJ; Zheng L; Zhang H; Huang S; Min J; Nicholson T; Chen T; Xu G; Shi Y; Zhang K; Shi YG
    Mol Cell; 2011 May; 42(4):451-64. PubMed ID: 21514197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TETology: Epigenetic Mastermind in Action.
    Seethy A; Pethusamy K; Chattopadhyay I; Sah R; Chopra A; Dhar R; Karmakar S
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1701-1726. PubMed ID: 33694104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells.
    Huang Y; Chavez L; Chang X; Wang X; Pastor WA; Kang J; Zepeda-Martínez JA; Pape UJ; Jacobsen SE; Peters B; Rao A
    Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1361-6. PubMed ID: 24474761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.